Abiopharma

Financial Statements and Related Announcement: Half Yearly Results

Response to SGX Queries:

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Changes in Interest of Chairman and Chief Executive Officer - Kong Wan Sing

General Announcement: UPDATES TO BOARD AND BOARD COMMITTEES

Tims China to Announce Second Quarter 2026 Financial Results on August 18, 2026

Change - Announcement of Appointment: APPOINTMENT OF DEPUTY CHIEF FINANCIAL OFFICER

Share Buy Back - Daily Share Buy-Back Notice: Share Buy Back - Daily Share Buy Back Notice

Deadline Approaching: Alarum Technologies, Ltd. (ALAR) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith

General Announcement: Announcement by Subsidiary Company, Millennium & Copthorne Hotels New Zealand Limited

General Announcement: Corporate Presentation